←Back to structures
envelope
Euk-VirKarumba_virus
envelope__YP_009389240__Karumba_virus__1969397
Identity
- Accession:
- YP_009389240 ↗
- Protein ID:
- envelope
- Kingdom:
- euk
Quality
73.8
mean pLDDT
Taxonomy
TaxID: 1969397
Cluster
View cluster (29 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 273-349
Domain cluster:
rep: envelope_protein__YP_009163750__Spanish_goat_encephalitis_virus__1691889__D312-394
D2
medium
residues 35-55_116-199_234-263
Domain cluster:
rep: uncovered_polypeptide_truncated_polyprotein__YP_009333101_0-788__Cacipacore_virus__64305__D209-229_336-350_412-434_469-522_547-584
CATH (18)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1rerA01 | 2.60.98.10 | Mainly Beta › Sandwich › Tick-borne Encephalitis virus Glycoprotein; domain 1 › Tick-borne Encephalitis virus Glycoprotein, domain 1 | 0.74 | 49.0 | 5.15e-01 | 98.5% | 72.2% |
| 6iw2A01 | 2.60.98.10 | Mainly Beta › Sandwich › Tick-borne Encephalitis virus Glycoprotein; domain 1 › Tick-borne Encephalitis virus Glycoprotein, domain 1 | 0.74 | 50.0 | 5.10e-01 | 100.0% | 69.9% |
| 6epkA02 | 3.30.67.10 | Alpha Beta › 2-Layer Sandwich › Viral Envelope Glycoprotein; domain 2 › Viral Envelope Glycoprotein, domain 2 | 0.72 | 37.0 | 5.29e-01 | 74.1% | 100.0% |
| 3p54A02 | 3.30.67.10 | Alpha Beta › 2-Layer Sandwich › Viral Envelope Glycoprotein; domain 2 › Viral Envelope Glycoprotein, domain 2 | 0.70 | 37.0 | 5.15e-01 | 74.1% | 100.0% |
| 1y8cA02 | 2.20.25.110 | Mainly Beta › Single Sheet › N-terminal domain of TfIIb › S-adenosyl-L-methionine-dependent methyltransferases | 0.66 | 25.0 | 3.58e-01 | 96.3% | 73.3% |
| 1mdcA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.63 | 33.0 | 3.42e-01 | 98.5% | 51.1% |
| 1vyfA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.63 | 34.0 | 3.44e-01 | 98.5% | 51.1% |
| 1okeB02 | 3.30.67.10 | Alpha Beta › 2-Layer Sandwich › Viral Envelope Glycoprotein; domain 2 › Viral Envelope Glycoprotein, domain 2 | 0.62 | 35.0 | 4.69e-01 | 74.1% | 100.0% |
| 1o8vA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.61 | 33.0 | 3.35e-01 | 98.5% | 51.9% |
| 2k3dA00 | 3.10.450.130 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › folded 79 residue fragment of lin0334 like domains | 0.56 | 26.0 | 3.18e-01 | 94.1% | 66.7% |
| 7dpyB01 | 2.40.128.200 | Mainly Beta › Beta Barrel › Lipocalin › C-type lysozyme inhibitor | 0.56 | 29.0 | 3.51e-01 | 98.5% | 78.3% |
| 4azpA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.55 | 33.0 | 3.34e-01 | 97.8% | 59.7% |
| 2m7oA00 | 3.10.450.400 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Uncharacterised protein PF15513, DUF4651 | 0.55 | 29.0 | 3.81e-01 | 87.4% | 97.1% |
| 2frxA02 | 3.10.450.720 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.54 | 35.0 | 3.34e-01 | 80.7% | 53.7% |
| 4oxwA00 | 3.30.1520.10 | Alpha Beta › 2-Layer Sandwich › PX Domain › Phox-like domain | 0.54 | 38.0 | 4.24e-01 | 97.8% | 92.5% |
| 6c1zA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.52 | 32.0 | 3.23e-01 | 98.5% | 60.1% |
| 1lfoA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.51 | 31.0 | 3.19e-01 | 96.3% | 62.2% |
| 2rcqA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.51 | 31.0 | 3.14e-01 | 97.8% | 58.9% |
ECOD (23)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4861488 | 5090.1.1.1 ↗ | beta complex topology › Viral glycoprotein, central and dimerisation domains-like › Viral glycoprotein, central and dimerisation domains › Viral glycoprotein, central and dimerisation domains › Flavi_glycoprot | 0.78 | 72.0 | 5.48e-01 | 100.0% | 85.4% |
| 2330240 | 5090.1.1.1 ↗ | beta complex topology › Viral glycoprotein, central and dimerisation domains-like › Viral glycoprotein, central and dimerisation domains › Viral glycoprotein, central and dimerisation domains › Flavi_glycoprot | 0.78 | 72.0 | 5.43e-01 | 100.0% | 82.8% |
| 406733 | 5090.1.1.3 ↗ | beta complex topology › Viral glycoprotein, central and dimerisation domains-like › Viral glycoprotein, central and dimerisation domains › Viral glycoprotein, central and dimerisation domains › Alpha_E1_glycop | 0.70 | 64.0 | 4.97e-01 | 100.0% | 88.1% |
| 3567966 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.65 | 32.0 | 3.75e-01 | 97.0% | 65.3% |
| 3487462 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.65 | 34.0 | 3.47e-01 | 97.0% | 51.5% |
| 3939474 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.64 | 35.0 | 3.41e-01 | 99.3% | 47.6% |
| 820 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.63 | 33.0 | 3.42e-01 | 98.5% | 51.1% |
| 3996508 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.63 | 34.0 | 3.34e-01 | 99.3% | 46.6% |
| 818 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.63 | 33.0 | 3.44e-01 | 98.5% | 51.9% |
| 2320506 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.63 | 36.0 | 3.55e-01 | 98.5% | 52.8% |
| 4668044 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.63 | 33.0 | 3.42e-01 | 97.8% | 51.9% |
| 4195832 | 9.1.1.24 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin_7 | 0.62 | 33.0 | 3.35e-01 | 97.8% | 51.5% |
| 4614038 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.61 | 32.0 | 3.31e-01 | 97.8% | 51.1% |
| 3941288 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.58 | 34.0 | 3.37e-01 | 99.3% | 53.1% |
| 3894563 | 9.1.1.24 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin_7 | 0.58 | 30.0 | 3.11e-01 | 96.3% | 50.8% |
| 3631472 | 247.1.1.0 ↗ | a+b four layers › Metallo-hydrolase/oxidoreductase › Metallo-hydrolase/oxidoreductase › Metallo-hydrolase/oxidoreductase | 0.57 | 31.0 | 2.66e-01 | 97.8% | 35.5% |
| 4046583 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.56 | 34.0 | 3.48e-01 | 97.8% | 62.3% |
| 2103558 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.53 | 32.0 | 3.26e-01 | 98.5% | 58.7% |
| 3598605 | 5.1.4.254 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › WD40, Beta-prop_NOL10_N | 0.52 | 34.0 | 2.53e-01 | 99.3% | 23.1% |
| 3415072 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.52 | 31.0 | 3.13e-01 | 97.8% | 57.1% |
| 2552758 | 9.1.1.24 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin_7 | 0.52 | 31.0 | 3.15e-01 | 97.0% | 58.4% |
| 4003909 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.50 | 31.0 | 2.87e-01 | 88.1% | 45.7% |
| 3813657 | 220.1.1.172 ↗ | beta barrels › PH domain-like › PH domain-like › PH domain-like › PH_PRMT_N | 0.50 | 25.0 | 2.73e-01 | 87.4% | 53.6% |
D3
medium
residues 56-115_200-233
Domain cluster:
rep: envelope_protein_E__YP_009227198__Zika_virus__64320__D55-128_231-256
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF00869.26 best | Flavi_glycoprot | 34.3 | 2.10e-08 | 91.5% | 19.7% |
D4
medium
residues 362-425